Steward Partners Investment Advisory, LLC Eli Lilly & CO Transaction History

Steward Partners Investment Advisory, LLC

$9.37 Billion
Q2 2024

A detailed history of Steward Partners Investment Advisory, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 60,909 shares of LLY stock, worth $55.2 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

60,909

Previous 62,002 1.76%

Holding current value

$55.2 Million

Previous $48.2 Million 14.33%

% of portfolio

0.59%

Previous 0.54%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $792,282 - $993,580	-1,093 Reduced 1.76%	60,909 $55.1 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $1.84 Million - $2.46 Million	3,107 Added 5.28%	62,002 $48.2 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $1.79 Million - $2.11 Million	3,401 Added 6.13%	58,895 $34.3 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $2.11 Million - $2.91 Million	-4,860 Reduced 8.05%	55,494 $29.8 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $643,257 - $860,109	-1,834 Reduced 2.95%	60,354 $28.3 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $1.78 Million - $2.09 Million	5,716 Added 10.12%	62,188 $21.4 Million
Q4 2022 Feb 15, 2023	BUY	$321.55 - $374.67 $576,860 - $672,157	1,794 Added 3.28%	56,472 $20.7 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $1.88 Million - $2.14 Million	6,337 Added 13.11%	54,678 $17.7 Million
Q2 2022 Aug 04, 2022	BUY	$278.73 - $327.27 $3.4 Million - $3.99 Million	12,198 Added 33.75%	48,341 $15.7 Million
Q1 2022 May 02, 2022	BUY	$234.69 - $291.66 $152,079 - $188,995	648 Added 1.83%	36,143 $10.4 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $191,122 - $237,184	850 Added 2.45%	35,495 $9.81 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $736,155 - $905,942	-3,322 Reduced 8.75%	34,645 $8.01 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $2.06 Million - $2.67 Million	-11,427 Reduced 23.13%	37,967 $8.71 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $3.46 Million - $4.48 Million	21,052 Added 74.28%	49,394 $9.23 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $90,800 - $120,150	-696 Reduced 2.4%	28,342 $4.79 Million
Q3 2020 Oct 30, 2020	BUY	$146.22 - $169.13 $297,557 - $344,179	2,035 Added 7.54%	29,038 $4.3 Million
Q2 2020 Aug 06, 2020	BUY	$136.42 - $164.18 $156,883 - $188,807	1,150 Added 4.45%	27,003 $4.43 Million
Q1 2020 Apr 29, 2020	SELL	$119.05 - $147.35 $39,167 - $48,478	-329 Reduced 1.26%	25,853 $3.59 Million
Q4 2019 Jan 17, 2020	BUY	$106.92 - $132.43 $20,528 - $25,426	192 Added 0.74%	26,182 $3.44 Million
Q3 2019 Oct 30, 2019	BUY	$106.79 - $116.16 $85,965 - $93,508	805 Added 3.2%	25,990 $2.91 Million
Q2 2019 Jul 25, 2019	BUY	$110.79 - $129.32 $178,482 - $208,334	1,611 Added 6.83%	25,185 $2.79 Million
Q1 2019 Apr 30, 2019	BUY	$111.31 - $131.02 $281,391 - $331,218	2,528 Added 12.01%	23,574 $3.06 Million
Q4 2018 Jan 15, 2019	BUY	$105.9 - $118.64 $50,302 - $56,354	475 Added 2.31%	21,046 $2.44 Million
Q3 2018 Oct 23, 2018	BUY	$85.86 - $107.31 $663,869 - $829,720	7,732 Added 60.22%	20,571 $2.21 Million
Q2 2018 Jul 20, 2018	BUY	$75.7 - $86.88 $93,186 - $106,949	1,231 Added 10.6%	12,839 $1.1 Million
Q1 2018 Apr 20, 2018	SELL	$74.21 - $87.6 $11,279 - $13,315	-152 Reduced 1.29%	11,608 $898,000
Q4 2017 Jan 19, 2018	BUY	$81.94 - $87.89 $85,545 - $91,757	1,044 Added 9.74%	11,760 $993,000
Q3 2017 Nov 22, 2017	BUY	$77.07 - $85.54 $59,498 - $66,036	772 Added 7.76%	10,716 $916,000
Q2 2017 Nov 22, 2017	SELL	N/A	-1,517 Reduced 13.24%	9,944 $818,000
Q1 2017 Nov 22, 2017	SELL	N/A	-52 Reduced 0.45%	11,461 $964,000
Q4 2016 Nov 22, 2017	BUY	N/A	11,513	11,513 $846,000

Others Institutions Holding LLY

# of Institutions

3,869

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $862B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account

Steward Partners Investment Advisory, LLC Eli Lilly & CO Transaction History